Skip to content

Ventria Bioscience

  • Medicines
    • Infectious Disease
    • Inflammatory Disease
  • Technology
    • ExpressTec
    • Evidence
    • In Context
    • Partnerships
    • BioShare
  • Our Purpose
  • About
    • People
    • Management
    • Board
    • News & Press
    • Contact Us
    • Careers
Medicines Our Science
  • Ventria Difference
  • Medicines
    • Infectious Disease
      • VEN BETA
    • Inflammatory Disease
      • VEN120
  • Technology
    • ExpressTec
    • Evidence
    • Partnerships
    • BioShare
  • About Us
    • Board
    • Careers
    • Contact Us
    • Management
    • People
    • News & Press
  • Newsletter Signup
  • Site map
  • Privacy Policy
  • FCOI Policy

Home / Partners / University of Minnesota

University of Minnesota

Ventria Bioscience has previously collaborated with Jason Baker, MD, MS at the University of Minnesota/Hennepin County Medical Center on a pilot clinical trial, Recombinant Human Lactoferrin to Reduce Immune Activation and Coagulation Among HIV Positive Patients: A pilot study.

Categories

  • In Context
  • News – Press

Recent

  • Secretory IgA: potential new weapon against respiratory transmission of SARS-CoV-2?
  • Could IgA from Human Breast Milk Offer Insights into Potential Treatments for COVID-19?
  • Ventria Bioscience’s ExpressTec Delivers the Power to Improve the Health Status of Children in Developing Countries
  • Human Milk Proteins: Their Power to Improve the Health Status of Children in Developing Countries
  • Design and Objectives of the ELCIE Clinical Trial

Subscribe today to our In Context blog feed, where you will be emailed the latest product news, research, and industry insights.

© Ventria Bioscience Inc. All Rights Reserved 2021

Sitemap | Terms & Privacy |